Director/PDMR Shareholding

RNS Number : 6893G

Eurocell plc

27 November 2020

 

27 November 2020

Eurocell plc

Director/PDMR Shareholding

Eurocell plc (the "Company") announces that, on 25 November 2020:

· options granted on 4 April 2017 under the Eurocell plc Deferred Share Plan 2015, to acquire ordinary shares in the Company, were exercised by 2 directors; and

· shares acquired, as a result of the above exercise, were sold by 2 directors to cover the associated tax and national insurance liabilities

The notifications set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	A - Mark Kelly B - Michael Scott
2.	Reason for the notification
a)	Position / status	A - Chief Executive Officer B - Chief Financial Officer
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Eurocell plc
b)	Legal Entity Identifier	213800RH62IQ7S9OFQ55
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49
b)	Nature of the transaction	Exercise of nil-cost options to acquire ordinary shares under the Eurocell plc Deferred Share Plan 2015
c)	Price(s) and volume(s)	Price(s) Volume(s) A - £nil (option price) B - £nil (option price) A - 51,049 B - 14,273
d)	Aggregated information -  Aggregated volume -  Aggregated price -  Aggregated total	N/A - single transactions
e)	Date of the transaction	25 November 2020
f)	Place of the transaction	Outside a trading venue

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	A - Mark Kelly B - Michael Scott
2.	Reason for the notification
a)	Position / status	A - Chief Executive Officer B - Chief Financial Officer
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Eurocell plc
b)	Legal Entity Identifier	213800RH62IQ7S9OFQ55
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Ordinary shares of £0.001 each in the Company ("Ordinary Shares") ISIN Number GB00BVV2KN49
b)	Nature of the transaction	Sale of ordinary shares, acquired under the Eurocell plc Deferred Share Plan 2015, to cover the associated tax and national insurance liabilities
c)	Price(s) and volume(s)	Price(s) Volume(s) A - £2.125 B - £2.125 A - 24,115 B - 6,743
d)	Aggregated information -  Aggregated volume -  Aggregated price -  Aggregated total	N/A - single transactions
e)	Date of the transaction	25 November 2020
f)	Place of the transaction	London Stock Exchange, Main Market (XLON)

For further information:

Eurocell plc  01773 842 100

Paul Walker

Group Company Secretary

 

END

 

 

DSHPPGQWGUPUGMQ